Sector Update: Biotechnology Stocks Showing The Way On NASDAQ

By Staff,

Shutterstock photo

Biotech stocks are helping to lead the market recovery today, currently up on average 1.4% as a group (SPSIBI) compared to the NASDAQ (COMP) market up 1.04% at 3,810.71. Year-to-date these specialty medical stocks focusing on pioneering advances in human therapeutics are up 48.9% compared to the NASDAQ's healthy gains of 26% year-to-date.

Stocks adding to the S&P Biotechnology Select Industry Index move higher are Amgen Inc ( AMGN ) up 2% at near $114 per share; ImmunoGen, Inc ( IMGN ) up 1.4% at $17.25 per share; and Neurocrine Biosciences Inc ( NBIX ) up 1.4% at $11.48 per share.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing Commodities
Referenced Stocks: AMGN , IMGN , NBIX

More from MT Newswires


MT Newswires

MT Newswires

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by